Skip to main content

Table 3 Patient Characteristics and ADAPT Scores by Transfer Outcome

From: Longitudinal assessment of preparation for care transition among adolescents and young adults with rheumatologic disease: a single-center pilot study

 

Completed Transfer

Visit Arranged

No Transfer Arranged

p-value

 

n = 8

n = 4

n = 19

 

Age

22.5 [21–23]

22 [21–22.5]

20 [19–21]

0.009

Education Level

   

0.007

 High School Graduate

0 (0)

0 (0)

6 (32)

 

 Some College

2 (25)

1 (25)

11 (58)

 

 College Graduate

6 (75)

3 (75)

2 (11)

 

Female

8 (100)

4 (100)

17 (89)

0.51

Primary Rheumatologic Disease

   

0.29

Juvenile Idiopathic Arthritis

4 (50)

4 (100)

14 (74)

 

Idiopathic Uveitis

0 (0)

0 (0)

1 (5)

 

Systemic Lupus Erythematosus

2 (25)

0 (0)

1 (5)

 

Mixed Connective Tissue Disease

2 (25)

0 (0)

0 (0)

 

Sjögren’s

0 (0)

0 (0)

1 (5)

 

Juvenile dermatomyositis

0 (0)

0 (0)

2 (11)

 

Composite scores: Baseline

n = 8

n = 4

n = 19

 

Total transition composite score (% yes)

0.68 [0.48–0.88]

0.52 [0.44–0.64]

0.45 [0.27–0.55]

0.01

Self-management (highest possible 4)

3 [2-3.5]

2.5 [1-2]

3 [1-3]

0.36

Transfer planning (highest possible 4)

3 [0.5–3.5]

1.5 [0.5-3]

0 [0–1]

0.005

 

n = 4

n = 2

n = 14

 

Medication counseling (highest possible 3)

2.5 [1.5-3]

3 [3]

2 [2,3]

0.29

Composite scores: Follow Up*

n = 1

n = 2

n = 17

 

Total transition composite score

0.64

0.56 [0.12-1.00]

0.50 [0.36–0.64]

0.80

Self-management

3

2.5 [1–4]

2 [1–3]

0.82

Transfer planning

3

2 [0–4]

0 [0–2]

0.37

 

n = 1

n = 1

n = 8

 

Medication counseling

1

3

2.5 [2, 3]

0.20

  1. *Only patients with last rheumatology visit within 12 months were eligible to complete follow-up ADAPT (n = 20). Medication and transfer composites applicable only to those patients screening in based on earlier questions